Deliver to United Kingdom
0

HPLC column NUCLEODUR ® Phenyl-Hexyl, 3 µm, 50 mm, 2 mm

£ 686.93*

*Prices plus VAT plus shipping costs

£ 824.32*

*incl. VAT, plus shipping costs

HPLC column NUCLEODUR ® Phenyl-Hexyl, 3 µm, 50 mm, 2 mm

Order number: 34LN.1

Part number: AC100007839

In Stock

Price Breakdown

1

6

24

Developed for demanding processing applications, the Hplc Column Nucleodur ® Phenyl-Hexyl, 3 μm, 50 Mm, 2 Mm offers exceptional performance in separating aromatic and unsaturated compounds, antibiotics, pharmaceutical products, steroids, and even those suitable for LC-MS. Featuring a reversed phase (RP) separation principle that utilizes both π-π and hydrophobic interactions, this column's unique phenylhexyl modification ensures low bleeding characteristics and high temperature stability up to 60°C. With a particle size of 3 μm, it boasts a specific surface area of 340 m²/g, providing optimal efficiency and resolution. Ideal for use with acetonitrile-water eluents, this fully porous particle (FPP) column offers pressure stability up to

  • Category: Separation columns for HPLC
  • Column shape: Analytical separation column
  • Surface chemistry: Phenylhexyl modification
  • Column type: HPLC column
  • Particle size: 3 µm
  • Particle type: Fully porous particles (FPP)
  • L x Ø internal (column): 50 x 2 mm
  • Column volume: 0.15 ml
  • Interactions / retention mechanism: π-π and hydrophobic
  • Specific surface according to BET: 340 m²/g
  • Phase: Phenyl-Hexyl
  • USP listing: L11
  • Endcapped: yes
  • Separation principle: Reversed phase (RP)
  • pH stability: 1,0-10,0
  • Pressure stability: 600 bar
  • Pore volume: 0.9 ml/g
  • Eluent in column: Acetonitrile - Water
  • Temperature stability: 60 ° C
  • Recommended application(s): Antibiotics Aromatic and unsaturated compounds Suitable for LC-MS Pharmaceutical products Especially for polar compounds Steroids
  • Pore size: 110 Å
allied chemi
  • secure-payment
  • visa
  • american-express
  • master-card

© 2026 Copyright. All Rights Reserved.